P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971512.00634.8e |
| _version_ | 1797280175246802944 |
|---|---|
| author | Catherine Thieblemont Christopher Fox Anthony Wang Kavita Sail Abualbishr Alshreef Michael Moran Alex Mutebi Julie Blaedel Viktor Chirikov Gilles Salles |
| author_facet | Catherine Thieblemont Christopher Fox Anthony Wang Kavita Sail Abualbishr Alshreef Michael Moran Alex Mutebi Julie Blaedel Viktor Chirikov Gilles Salles |
| author_sort | Catherine Thieblemont |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:36:17Z |
| format | Article |
| id | doaj.art-58e75a3fa456429f8b0396cffeac5e0e |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:36:17Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-58e75a3fa456429f8b0396cffeac5e0e2024-03-03T09:43:14ZengWileyHemaSphere2572-92412023-08-017e006348e10.1097/01.HS9.0000971512.00634.8e202308003-01052P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISONCatherine Thieblemont0Christopher Fox1Anthony Wang2Kavita Sail3Abualbishr Alshreef4Michael Moran5Alex Mutebi6Julie Blaedel7Viktor Chirikov8Gilles Salles91 Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France2 Department of Haematology, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United States3 AbbVie, Inc., North Chicago, IL, United States3 AbbVie, Inc., North Chicago, IL, United States3 AbbVie, Inc., North Chicago, IL, United States3 AbbVie, Inc., North Chicago, IL, United States4 Genmab US Inc., Plainsboro, NJ, United States4 Genmab US Inc., Plainsboro, NJ, United States5 OPEN Health, Bethesda, MD, United States6 Memorial Sloan Kettering Cancer Center, New York, NY, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000971512.00634.8e |
| spellingShingle | Catherine Thieblemont Christopher Fox Anthony Wang Kavita Sail Abualbishr Alshreef Michael Moran Alex Mutebi Julie Blaedel Viktor Chirikov Gilles Salles P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON HemaSphere |
| title | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_full | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_fullStr | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_full_unstemmed | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_short | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_sort | p1154 efficacy of subcutaneous epcoritamab vs axi cel in r r dlbcl car t naive and car t eligible patients an indirect comparison |
| url | http://journals.lww.com/10.1097/01.HS9.0000971512.00634.8e |
| work_keys_str_mv | AT catherinethieblemont p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT christopherfox p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT anthonywang p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT kavitasail p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT abualbishralshreef p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT michaelmoran p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT alexmutebi p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT julieblaedel p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT viktorchirikov p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT gillessalles p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison |